3Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellittts[J]. Proc Natl Acad Sci U S A, 1981, 78(8) : 5190-5192.
4Vlassara H, Brownlee M, Cerami A. Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats[J]. Diabetes, 1983, 32(7): 670-674.
5Cerami A, Vlassara H, Brownlee M. Role of advanced glycosylation products in complications of diabetes[J]. Diabetes Care 1988,11 Suppl 1 : 73-79.
6Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation:role in the pathogenesis of diabetic complications[J]. Clin Chem,1986, 32(10 Suppl): B37-41.
7Cullum NA, Mahon J, Stringer K, et al. Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus[J]. Diabetologia,1991, 34(6) : 387-389.
8Ryle C, Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human diabetics[J]. J Neurol Sci, 1995, 129(1) : 62.
9Sensi M, Pricci F, Pugliese G, et al. Role of advanced glycation end-products (AGE) in late diabetic complications [J]. Diabetes Res Clin Pract, 1995, 28(1) : 9-17.
10Mitsuhashi T, Vlassara H, Founds HW, et al. Standardizing the immunological measurement of advanced glycation end products using normal human serum[J]. J Immunol Methods, 1997, 207(1):79-88.
